BIRCHBIOMED
BirchBioMed is a clinical-stage biomedical company focused on the clinical evaluation. It specializes in development and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded in 2015 and headquartered in King City, Ontario.
BIRCHBIOMED
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
King City, Ontario, Canada
Country:
Canada
Website Url:
http://www.birchbiomed.ca
Total Employee:
1+
Status:
Active
Total Funding:
5.3 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
Sierra Biomedical
Sierra Biomedical is a pre-clinical biomedical services company.
Current Employees Featured
Founder
Investors List
National Institute for Health Research
National Institute for Health Research investment in Venture Round - BirchBioMed
entrepreneurship@UBC
entrepreneurship@UBC investment in Pre Seed Round - BirchBioMed
Key Employee Changes
| Date | New article |
|---|---|
| 2021-04-15 | BirchBioMed Welcomes Dr. Jonathan Bourne as New Chief Science Officer |
Official Site Inspections
http://www.birchbiomed.ca
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BirchBioMed"
BirchBioMed - Anti-scarring | Auto-immune Therapeutics
BirchBioMed is dedicated to addressing some of the most urgent and challenging health conditions, including organ fibrosis, specific autoimmune disorders, and skin-related ailments. …See details»
Our Mission – BirchBioMed
BirchBioMed is a clinical-stage biopharmaceutical company headquartered in Canada. We are dedicated to the development of innovative treatments for organ fibrosis, scarring, related skin …See details»
BirchBioMed Gains Health Canada Green Light for …
Oct 25, 2024 “In this process, BirchBioMed selected SGS Nutrasource as our Contract Research Organization. An innovative leader in the biopharmaceutical world, SGS …See details»
BirchBioMed - Crunchbase Company Profile & Funding
BirchBioMed is a clinical-stage biomedical company. Search Crunchbase. Start Free Trial . Chrome Extension. ... birchbiomed.ca ; 106,262; Highlights. …See details»
BirchBioMed Inc. - LinkedIn
BirchBioMed Inc., a clinical-stage biomedical company focused on the clinical evaluation, development and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for ...See details»
BirchBioMed Receives Health Canada Green Light to Start the Last …
Contact Us Today. Find out how Nutrasource can help you commercialize your innovations. Contact Us. October 24, 2024. Guelph, October 24, 2024: BirchBioMed, a leading …See details»
BirchBioMed Receives Health Canada Green Light to Start the Last …
Oct 24, 2024 BirchBioMed, a leading biopharmaceutical company expert in the development of products for scarring and other fibrosis-related disorders, announced the authorization from …See details»
Mark Miller - Chairman & CEO - BirchBioMed Inc.
Chairman & CEO · Chairman/CEO of BirchBioMed Inc., a clinical stage biopharmaceutical company focused on developing treatments for scarring …See details»
BirchBioMed Welcomes Dr. Jonathan Bourne as New …
Apr 15, 2021 BirchBioMed, a University of British Columbia ... www.birchbiomed.ca. × Modal title. Organization Profile. BirchBioMed. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET ...See details»
Leadership – BirchBioMed
He is the co-founder of BirchBioMed, the co-founder and Board Chairman of The Carlisle Group, Inc., a full service marketing and publishing company, Board Chairman of Trivest-Global …See details»
BirchBioMed Inc. Announces Positive Topline Data from Phase
Jan 22, 2021 www.birchbiomed.ca. × Modal title. Organization Profile. BirchBioMed. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a Demo ; …See details»
BirchBioMed is cleared to begin first-of-its-kind phase II
Feb 16, 2018 /CNW/ - BirchBioMed Inc. a biomedical company focused on the commercialization, clinical evaluation and development of proprietary anti-scarring drugs,...See details»
BirchBioMed Receives Health Canada Green Light to Start the Last …
BirchBioMed recently announced the authorization from Health Canada to conduct its Phase 2/3 randomized clinical trial of a naturally based compound, FS2, at multiple centers of expertise …See details»
BirchBioMed Gains Health Canada Green Light for …
Oct 25, 2024 “In this process, BirchBioMed selected SGS Nutrasource as our Contract Research Organization. An innovative leader in the biopharmaceutical world, SGS …See details»
University of British Columbia – BirchBioMed
As a University of British Columbia (“UBC”) spin-off, BirchBioMed took on the significant challenge of developing FS2 and AI-001 as major therapeutic agents to be made available to millions of …See details»
BirchBioMed Company Profile 2024: Valuation, Funding
BirchBioMed General Information Description. Operator of a clinical-stage biomedical agency intended to develop anti-scarring drugs. The company focuses on the clinical evaluation, …See details»
BirchBioMed Gains Health Canada Green Light for …
Oct 25, 2024 BirchBioMed is a pioneering clinical stage biopharmaceutical company focused on developing novel, breakthrough treatments for organ fibrosis, scarring, skin disorders, and …See details»
BirchBioMed Receives Health Canada Green Light to Start the Last …
Oct 24, 2024 GENEVA, SWITZERLAND / AGILITYPR.NEWS / October 24, 2024 / Guelph, October 22, 2024: BirchBioMed, a leading biopharmaceutical company expert in the …See details»
Our Science – BirchBioMed
BirchBioMed is at the forefront of biopharmaceutical innovation, focusing on the development of advanced treatments for fibrosis and certain autoimmune disorders. Our science centers …See details»